Decipher Labs share price
You have to be logged in to add this to Watchlist.- ₹11.34(-3.16%)May 16, 2025 15:26:40 PM IST
- NSE
- BSE
- Vol : 17.63K (NSE + BSE)Last 20 day avg : 7.57 K
Decipher Labs is trading -3.16% lower at Rs 11.34 as compared to its last closing price. Decipher Labs has been trading in the price range of 11.94 & 10.40. Decipher Labs has given -25.08% in this year & 3.32% in the last 5 days. Decipher Labs has TTM P/E ratio 63.49 as compared to the sector P/E of 24.40.The company posted a net profit of -0.59 Crores in its last quarter.Listed peers of Decipher Labs include Colinz Laboratories (0.87%), Vanta Bioscience (4.98%), Decipher Labs (-3.16%).The Mutual Fund holding in Decipher Labs was at -% in . The MF holding has - from the last quarter. The FII holding in Decipher Labs was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on May 17, 2025, 07:10 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.52The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values47.57Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.80Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable- The company's revenue fell during December quarter by 29.95% from Rs 8.29 crore to Rs 5.80 crore, year-on-year
- Company has registered a loss of 0.59 cr vs a profit of 0.01 cr in the same quarter last year.
- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 12.57
- R2
- 13.58
- R3
- 14.67
- S1
- 10.47
- S2
- 9.38
- S3
- 8.37
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Colinz Laboratories | Neutral | 58.00 | 0.87 | 14.61 | 29.79 | 1.62 | - | - |
| Vanta Bioscience | Neutral | 23.18 | 4.98 | 14.63 | - | 0.92 | - | 321.09 |
| Decipher Labs | Bearish | 11.34 | -3.16 | 11.46 | - | 0.54 | - | - |
| Unjha Formulations | Bearish | 23.01 | -0.99 | 10.31 | 37.47 | 3.81 | - | - |
| Beryl Drugs | Moderately Bearish | 19.40 | -4.90 | 9.84 | 13.61 | 1.16 | - | 26.94 |
- Promoter(s) does not have a high stake in the company
- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
| 2024-05-30 | Audited Results |
| 2024-02-14 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE643N01012
- BSE Code524752
- NSE Code
Decipher Labs is trading at 11.34 as on Fri May 16 2025 09:56:40. This is -3.16% lower as compared to its previous closing price of 11.71.
The market capitalization of Decipher Labs is 11.46 Cr as on Fri May 16 2025 09:56:40.
The 52 wk high for Decipher Labs is 24.60 whereas the 52 wk low is 10.01
Decipher Labs can be analyzed on the following key metrics -
- TTM P/E: 63.49
- Sector P/E: 24.40
- Dividend Yield: 0.00%
- D/E ratio: -
Decipher Labs reported a net profit of -1.68 Cr in 2024.